Proposed Model for Evaluating Real-world Laboratory Results for Big Data Research

참고문헌 (8)

1. EurA1c Trial Group, "EurA1c : the European HbA1c trial to investigate the performance of HbA1c assays in 2166 laboratories across 17 countries and 24 manufacturers by use of the IFCC model for quality targets", Clin Chem, 64, pp.1183~1192 (2018)
2. Thompson S, "Lot-to-lot variation", Clin Biochem Rev, 39, pp.51~60 (2018)
3. Thaler MA, "Clinically relevant lot-to-lot reagent difference in a commercial immunoturbidimetric assay for glycated hemoglobin A1c", Clin Biochem, 48, pp.1167~1170 (2015)
4. "The International Consortium for Harmonization of Clinical Laboratory Results" (2022)[URL]
5. Jeong Tae-Dong, "Recent Trends in Creatinine Assays in Korea: Long-Term Accuracy-Based Proficiency Testing Survey Data by the Korean Association of External Quality Assessment Service (2011–2019)", Annals of Laboratory Medicine, 41(4), pp.372~379 (2021), 대한진단검사의학회[DOI]
6. Kim Sollip, "Schemes and Performance Evaluation Criteria of Korean Association of External Quality Assessment (KEQAS) for Improving Laboratory Testing", Annals of Laboratory Medicine, 41(2), pp.230~239 (2021), 대한진단검사의학회[DOI]
7. Weykamp C, "Investigation of 2 models to set and evaluate quality targets for hb a1c : biological variation and sigma-metrics", Clin Chem, 61, pp.752~759 (2015)
8. "IFCC network for standardization of HbA1c" (2022)[URL]

관련 논문AI추천